Implantable system for the diagnostic and/or therapeutic treatment of a human patient or an animal patient

Patent metadata

Field	Value
Publication number	US-11684787-B2
Application number	US-202016835619-A
Country	US
Kind code	B2
Filing date	Mar 31, 2020
Priority date	Apr 18, 2019
Publication date	Jun 27, 2023
Grant date	Jun 27, 2023

Abstract

An implantable system for the diagnostic and/or therapeutic treatment of a human or animal patient contains a processor, a memory, a treatment unit and a remote data transmission unit. The system is characterized in that the memory includes a computer-readable program which prompts the processor to carry out the following steps when the program is being executed on the processor: a) ascertaining whether a treatment functionality of the treatment unit could jeopardize a patient in whom the system was implanted if a diagnostic and/or therapeutic treatment of the patient corresponding to the treatment functionality were to be carried out; b) deactivating the treatment functionality when a potential risk for the patient was ascertained; c) receiving reactivation data by way of the remote data transmission unit; and d) reactivating the deactivated treatment functionality based on the received reactivation data.

First claim

The invention claimed is:

1. An implantable system for a diagnostic and/or therapeutic treatment of a heart of a patient including a human patient or an animal patient, the implantable system comprising:
a processor;
a treatment unit;
a remote data transmitter;
a memory storing a computer-readable program, which prompts said processor to carry out the following steps when the computer-readable program is being executed on said processor:
delivering, by said treatment unit, atrial antitachycardia stimulation to the heart of the patient and then reducing a risk of thrombosis by deactivating an ability of said treatment unit to deliver further atrial antitachycardia stimulation after an expiration of a presettable time, the presettable time being a time period of about 48 hours and after which an unsuccessful treatment of atrial tachycardia increases the patient's risk of thrombosis;
receiving reactivation data by way of said remote data transmitter; and
reactivating the ability of said treatment unit to subsequently deliver the further atrial antitachycardia stimulation based on the reactivation data that was received.

2. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to transmit status data by way of said remote data transmitter which indicates whether a particular treatment functionality of said treatment unit is activated or deactivated.

3. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to permit a reactivation of treatment functionalities assigned to a first group, based on received reactivation data, and/or to disallow a reactivation of treatment functionalities assigned to a second group, based on the received reactivation data.

4. The implantable system according to claim 3 , wherein said memory stores assignment data for assigning the treatment functionalities to the first group or to the second group, and wherein the computer-readable program prompts said processor to assign the treatment functionalities to the first group or to the second group based on the assignment data.

5. The implantable system according to claim 4 , further comprising a near field telemetry unit, and the computer-readable program prompts said processor to receive the assignment data by way of said near field telemetry unit.

6. The implantable system according to claim 1 , wherein the implantable system is configured for treating a human heart or an animal heart.

7. A treatment system, comprising:
an implantable system for a diagnostic and/or therapeutic treatment of a heart of a patient including a human patient or an animal patient, said implantable system containing a first processor, a first memory, a treatment unit and a first remote data transmitter;
a remote access unit disposed remotely from said implantable system, said remote access unit containing a second processor, a second memory and a second remote data transmitter;
said first memory storing a first computer-readable program, which prompts said first processor to carry out the following steps when the first computer-readable program is being executed on said first processor:
delivering, by said treatment unit, atrial antitachycardia stimulation to the heart of the patient and then reducing a risk of thrombosis by deactivating an ability of said treatment unit to deliver further atrial antitachycardia stimulation after an expiration of a presettable time, the presettable time being a time period of about 48 hours and after which an unsuccessful treatment of atrial tachycardia increases the patient's risk of thrombosis;
receiving reactivation data by way of the first remote data transmitter; and
reactivating the ability of said treatment unit to subsequently deliver the further atrial antitachycardia stimulation based on the reactivation data that was received; and

said second memory unit storing a second computer-readable program, which prompts said second processor to carry out the following steps when the second computer-readable program is being executed on said second processor:
generating the reactivation data in response to an input or a program request; and
transmitting the reactivation data by way of the second remote data transmitter.

8. The treatment system according to claim 7 , wherein the second computer-readable program prompts said second processor to receive status data of said implantable system prior to a generation of the reactivation data by way of the second remote data transmitter, which indicates whether a particular treatment functionality of said treatment unit is activated or deactivated.

9. A method for controlling an operation of an implantable system for a diagnostic and/or therapeutic treatment of a heart of a patient including a human patient or an animal patient, which comprises the following steps of:
delivering, by a treatment unit of the implantable system, atrial antitachycardia stimulation to the heart of the patient and then reducing a risk of thrombosis by deactivating an ability of the treatment unit to deliver further atrial antitachycardia stimulation after an expiration of a presettable time, the presettable time being a time period of about 48 hours and after which an unsuccessful treatment of atrial tachycardia increases the patient's risk of thrombosis;
receiving reactivation data by way of a remote data transmission unit; and
reactivating the ability of the treatment unit to subsequently deliver the further atrial antitachycardia stimulation based on the reactivation data that was received.

10. A non-transitory computer medium storing a computer program product having computer-readable code, which prompts a processor to carry out the following steps when the computer-readable code is being executed on the processor:
delivering, by a treatment unit of an implanted system, atrial antitachycardia stimulation to a heart of a patient and then reducing a risk of thrombosis by deactivating an ability of the treatment unit to deliver further atrial antitachycardia stimulation after an expiration of a presettable time, wherein the implanted system is configured at least for a therapeutic treatment of a heart of a patient, including a human patient or an animal patient, the presettable time being a time period of about 48 hours and after which an unsuccessful treatment of atrial tachycardia increases the patient's risk of thrombosis;
receiving reactivation data by way of a remote data transmission unit; and
reactivating the ability of the treatment unit to subsequently deliver the further atrial antitachycardia stimulation based on the reactivation data that was received.

11. A method for treating a patient including a human patient or an animal patient requiring treatment, by way of an implantable system which performs a diagnostic and/or therapeutic treatment of the human patient or the animal patient, the implantable system containing a processor, a memory, a treatment unit and a remote data transmitter, the method comprises the following steps of:
delivering, by the treatment unit of the implantable system, atrial antitachycardia stimulation to the heart of the patient and then reducing a risk of thrombosis by deactivating an ability of the treatment unit to deliver further atrial antitachycardia stimulation after an expiration of a presettable time, the presettable time being a time period of about 48 hours and after which an unsuccessful treatment of atrial tachycardia increases the patient's risk of thrombosis;
receiving reactivation data by way of the remote data transmitter;
reactivating the ability of the treatment unit to subsequently deliver the further atrial antitach

Assignees

• Biotronik Se & Co Kg

Inventors

• Doerr Thomas
• Ershov Sergey
• Radtke Torsten
• Roemer Martin
• Weiss Ingo

Classifications

• A61N1/39622

  Pacing therapy · CPC title

• A61N1/3621

  for treating or preventing abnormally high heart rate · CPC title

• A61N1/08

  Arrangements or circuits for monitoring, protecting, controlling or indicating {(for external stimulators A61N1/3603; for implantable neurostimulators A61N1/36128; for heart stimulators A61N1/37; for defibrillators A61N1/3925)} · CPC title

• A61N1/36128

  Control systems · CPC title

• A61N1/37282 Primary

  characterised by communication with experts in remote locations using a network · CPC title